Profile data is unavailable for this security.
About the company
U.S. Physical Therapy, Inc. is engaged in physical therapy operations and provides industrial injury prevention services. The Company is engaged in physical therapy operations primarily through its subsidiary, clinic partnerships. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically related injuries and rehabilitation of injured workers. It operates approximately 683 outpatient physical therapy clinics in 42 states. In addition to owning and operating clinics, the Company manages about 41 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention business which provides onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
- Revenue in USD (TTM)611.97m
- Net income in USD17.62m
- Incorporated1992
- Employees3.90k
- LocationUS Physical Therapy Inc1300 West Sam Houston Parkway, Suite 300HOUSTON 77043United StatesUSA
- Phone+1 (713) 297-7000
- Fax+1 (713) 297-7090
- Websitehttps://www.usph.com/
Mergers & acquisitions
Acquired company | USPH:NYQ since announced | Transaction value |
---|---|---|
Undisclosed Physical Therapy & Hand Therapy Practice(9) | -6.86% | 16.40m |
Undisclosed Physical Therapy Practice(2) | 14.60% | 13.90m |
Undisclosed Clinic Physical Therapy Practice(5) | -9.59% | 2.10m |
Undisclosed Four-Clinic Physical Therapy Practice Co | 5.46% | 3.10m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brookdale Senior Living, Inc. | 3.05bn | -174.03m | 1.33bn | 25.20k | -- | 3.56 | 7.48 | 0.4367 | -0.7717 | -0.7717 | 13.50 | 1.94 | 0.533 | -- | 59.56 | 120,849.10 | -3.05 | -2.20 | -3.45 | -2.48 | 25.07 | 21.71 | -5.72 | -4.40 | -- | 0.1681 | 0.9124 | -- | 6.74 | -7.82 | 20.73 | -- | -12.60 | -- |
Alignment Healthcare Inc | 2.01bn | -157.25m | 1.42bn | 1.54k | -- | 10.88 | -- | 0.7076 | -0.837 | -0.837 | 10.73 | 0.6849 | 2.89 | -- | 13.87 | 1,310,596.00 | -22.56 | -- | -45.76 | -- | 10.61 | -- | -7.82 | -- | -- | -6.19 | 0.551 | -- | 27.16 | -- | 1.02 | -- | -- | -- |
National HealthCare Corporation | 1.17bn | 81.29m | 1.52bn | 13.12k | 18.69 | 1.64 | 12.33 | 1.30 | 5.26 | 5.26 | 75.85 | 60.05 | 0.9046 | 106.16 | 10.22 | 89,092.20 | 6.21 | 5.12 | 7.33 | 6.21 | 37.76 | 39.84 | 6.86 | 6.28 | 1.99 | -- | 0.00 | 49.35 | 5.14 | 3.09 | 197.61 | 2.03 | -1.29 | 3.43 |
US Physical Therapy Inc | 611.97m | 17.62m | 1.60bn | 3.90k | 86.16 | 3.33 | 29.87 | 2.61 | 1.23 | 1.23 | 41.69 | 31.84 | 0.6492 | -- | 8.07 | 156,955.10 | 3.97 | 7.13 | 5.61 | 10.64 | 19.45 | 21.96 | 6.11 | 9.71 | -- | 32.56 | 0.1785 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
Veracyte Inc | 375.47m | -68.18m | 1.67bn | 815.00 | -- | 1.49 | -- | 4.43 | -0.9346 | -0.9346 | 5.12 | 14.64 | 0.3186 | 7.47 | 8.15 | 460,703.10 | -5.78 | -6.33 | -6.08 | -6.69 | 68.54 | 67.10 | -18.16 | -20.99 | 4.69 | -- | 0.00009 | -- | 21.76 | 31.45 | -103.51 | -- | 39.67 | -- |
Addus Homecare Corporation | 1.09bn | 65.67m | 1.81bn | 6.06k | 27.52 | 2.50 | 22.72 | 1.67 | 4.02 | 4.02 | 66.67 | 44.30 | 1.12 | -- | 9.45 | 179,534.30 | 6.75 | 5.18 | 7.82 | 6.04 | 32.12 | 30.88 | 6.04 | 4.96 | -- | 10.02 | 0.1205 | 0.00 | 11.31 | 15.43 | 35.83 | 30.83 | 12.06 | -- |
NeoGenomics, Inc. | 610.66m | -84.23m | 1.89bn | 2.10k | -- | 2.04 | -- | 3.09 | -0.6698 | -0.6698 | 4.86 | 7.25 | 0.3646 | 15.88 | 4.69 | 290,791.90 | -5.03 | -3.57 | -5.29 | -3.80 | 41.80 | 41.09 | -13.79 | -9.36 | 7.22 | -- | 0.3685 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
Astrana Health Inc | 1.45bn | 62.42m | 1.90bn | 1.80k | 29.37 | 2.83 | 23.55 | 1.31 | 1.32 | 1.32 | 30.85 | 13.77 | 1.31 | -- | 8.64 | 807,652.30 | 5.61 | 7.09 | 6.61 | 9.39 | 16.58 | 18.30 | 4.28 | 6.36 | -- | 61.71 | 0.4635 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
Brightspring Health Services Inc | 8.83bn | -154.60m | 1.91bn | 35.00k | -- | 2.25 | 41.98 | 0.2164 | -0.9204 | -0.9204 | 57.53 | 4.96 | -- | -- | -- | 252,176.40 | -- | -- | -- | -- | 16.24 | 17.75 | -1.78 | -0.6289 | 0.8442 | 0.9783 | 0.8473 | -- | 14.32 | 28.33 | -186.80 | -- | 17.24 | -- |
Privia Health Group Inc | 1.69bn | 18.74m | 1.93bn | 1.10k | 107.55 | 3.32 | 78.03 | 1.14 | 0.1502 | 0.1502 | 13.51 | 4.86 | 1.77 | -- | 5.56 | 1,530,584.00 | 1.85 | -- | 3.20 | -- | 9.67 | 9.15 | 1.05 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
Teladoc Health Inc | 2.62bn | -233.03m | 2.01bn | 5.60k | -- | 0.8751 | 15.18 | 0.7659 | -1.40 | -1.40 | 15.80 | 13.52 | 0.607 | 19.58 | 12.18 | 467,732.50 | -5.40 | -33.54 | -5.93 | -34.63 | 70.81 | 68.59 | -8.90 | -171.39 | 3.74 | -- | 0.4021 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
Agilon Health Inc | 4.78bn | -207.85m | 2.28bn | 1.12k | -- | 3.31 | -- | 0.477 | -0.5182 | -0.71 | 11.78 | 1.68 | 2.13 | -- | 3.71 | 4,283,411.00 | -9.27 | -- | -20.91 | -- | 6.37 | -- | -4.35 | -- | -- | -- | 0.0514 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Mar 2024 | 2.15m | 14.29% |
Kayne Anderson Rudnick Investment Management LLCas of 31 Mar 2024 | 1.32m | 8.79% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.03m | 6.85% |
Calvert Research & Managementas of 31 Mar 2024 | 800.38k | 5.31% |
T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 773.01k | 5.13% |
Copeland Capital Management LLCas of 31 Mar 2024 | 770.22k | 5.11% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 578.90k | 3.84% |
Boston Trust Walden, Inc.as of 31 Mar 2024 | 544.17k | 3.61% |
SouthernSun Asset Management LLCas of 31 Mar 2024 | 459.12k | 3.05% |
Schroder Investment Management North America, Inc.as of 31 Mar 2024 | 415.34k | 2.76% |